1. Outcomes by line of therapy and programmed death ligand 1 expression in patients with advanced melanoma treated with pembrolizumab or ipilimumab in KEYNOTE-006: A randomised clinical trial. (September 2018) Authors: Carlino, Matteo S.; Long, Georgina V.; Schadendorf, Dirk; Robert, Caroline; Ribas, Antoni; Richtig, Erika; Nyakas, Marta; Caglevic, Christian; Tarhini, Ahmed; Blank, Christian; Hoeller, Christoph; Bar-Sela, Gil; Barrow, Catherine; Wolter, Pascal; Zhou, Honghong; Emancipator, Kenneth; Jensen, Erin... Journal: European journal of cancer Issue: Volume 101(2018) Page Start: 236 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Patient-reported quality of life in patients with relapsed/refractory cutaneous T-cell lymphoma: Results from the randomised phase III ALCANZA study. (July 2020) Authors: Dummer, Reinhard; Prince, Henry M.; Whittaker, Sean; Horwitz, Steven M.; Kim, Youn H.; Scarisbrick, Julia; Quaglino, Pietro; Zinzani, Pier Luigi; Wolter, Pascal; Eradat, Herbert; Pinter-Brown, Lauren; Sanches, Jose A.; Ortiz-Romero, Pablo L.; Akilov, Oleg E.; Geskin, Larisa; Huen, Auris; Walewski... Journal: European journal of cancer Issue: Volume 133(2020) Page Start: 120 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Melanoma susceptibility variant rs869330 in the MTAP gene is associated with melanoma outcome. Issue 6 (December 2019) Authors: Marasigan, Vivien; Güvenç, Canan; van den Oord, Joost J.; Stas, Marguerite; Boecxstaens, Veerle; Bechter, Oliver; Wolter, Pascal; Lambrechts, Diether; Garmyn, Marjan Journal: Melanoma research Issue: Volume 29:Issue 6(2019) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. The impact of patient characteristics and disease-specific factors on first-line treatment decisions for BRAF-mutated melanoma: results from a European expert panel study. Issue 4 (August 2018) Authors: Ascierto, Paolo A.; Bastholt, Lars; Ferrucci, Pier F.; Hansson, Johan; Márquez Rodas, Iván; Payne, Miranda; Robert, Caroline; Thomas, Luc; Utikal, Jochen S.; Wolter, Pascal; Kudlac, Amber; Tuson, Harriet; McKendrick, Jan Journal: Melanoma research Issue: Volume 28:Issue 4(2018) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Prospective evaluation of hypogonadism in male metastatic renal cell carcinoma patients treated with targeted therapies. Issue 3 (4th May 2019) Authors: Bastin, Julie; Werbrouck, Emilie; Verbiest, Annelies; Punie, Kevin; Bechter, Oliver; Woei-A-Jin, Feng Jung; Wolter, Pascal; Wildiers, Hans; Lerut, Evelyne; Dumez, Herlinde; Decallonne, Brigitte; Clement, Paul; Vanderschueren, Dirk; Albersen, Maarten; Oyen, Raymond; Schöffski, Patrick; Beuselinck,... Journal: Acta clinica belgica Issue: Volume 74:Issue 3(2019) Page Start: 169 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. ABCG2 Polymorphism rs2231142 and hypothyroidism in metastatic renal cell carcinoma patients treated with sunitinib. Issue 3 (4th May 2019) Authors: Werbrouck, Emilie; Bastin, Julie; Lambrechts, Diether; Verbiest, Annelies; Van Brussel, Thomas; Lerut, Evelyne; Machiels, Jean-Pascal; Verschaeve, Vincent; Richard, Vincent; Debruyne, Philip R.; Decallonne, Brigitte; Schöffski, Patrick; Bechter, Oliver; Wolter, Pascal; Beuselinck, Benoit Journal: Acta clinica belgica Issue: Volume 74:Issue 3(2019) Page Start: 180 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Prognostic factors in second-line targeted therapy for metastatic clear-cell renal cell carcinoma after progression on an anti-vascular endothelial growth factor receptor tyrosine kinase inhibitor. (3rd March 2016) Authors: Sacré, Anne; Barthélémy, Philippe; Korenbaum, Clement; Burgy, Mickael; Wolter, Pascal; Dumez, Herlinde; Lerut, Evelyne; Loyson, Tine; Joniau, Steven; Oyen, Raymond; Debruyne, Philip R.; Schöffski, Patrick; Beuselinck, Benoit Journal: Acta oncologica Issue: Volume 55:Number 3(2016) Page Start: 329 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Response to brentuximab vedotin versus physician's choice by CD30 expression and large cell transformation status in patients with mycosis fungoides: An ALCANZA sub-analysis. (May 2021) Authors: Kim, Youn H.; Prince, H. Miles; Whittaker, Sean; Horwitz, Steven M.; Duvic, Madeleine; Bechter, Oliver; Sanches, Jose A.; Stadler, Rudolf; Scarisbrick, Julia; Quaglino, Pietro; Zinzani, Pier Luigi; Wolter, Pascal; Eradat, Herbert; Pinter-Brown, Lauren C.; Ortiz-Romero, Pablo L.; Akilov, Oleg E.; ... Journal: European journal of cancer Issue: Volume 148(2021) Page Start: 411 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. A randomized, open‐label clinical trial of tasisulam sodium versus paclitaxel as second‐line treatment in patients with metastatic melanoma. Issue 13 (26th March 2014) Authors: Hamid, Omid; Ilaria, Robert; Garbe, Claus; Wolter, Pascal; Maio, Michele; Hutson, Thomas E.; Arance, Ana; Lorigan, Paul; Lee, Jeeyun; Hauschild, Axel; Mohr, Peter; Hahka‐Kemppinen, Marjo; Kaiser, Christopher; Turner, P. Kellie; Conti, Ilaria; Grob, Jean‐Jacques Journal: Cancer Issue: Volume 120:Issue 13(2014) Page Start: 2016 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Improving lymph node characterization in staging malignant lymphoma using first‐order ADC texture analysis from whole‐body diffusion‐weighted MRI. Issue 4 (14th April 2018) Authors: De Paepe, Katja N.; De Keyzer, Frederik; Wolter, Pascal; Bechter, Oliver; Dierickx, Daan; Janssens, Ann; Verhoef, Gregor; Oyen, Raymond; Vandecaveye, Vincent Journal: Journal of magnetic resonance imaging Issue: Volume 48:Issue 4(2018) Page Start: 897 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗